Anthem Biosciences submitted an SEBI Reg. 30 & 46 compliance filing regarding its FY26 earnings call.
The audio recording for the analyst call on audited Q4 and full-year FY26 results is now available online.
The earnings call was held on May 20, 2026, and discussed both standalone and consolidated financial performance.